Please enter your license information:
Renal Excretion
Trajenta®: The only DPP-4i primarily excreted via a non-renal route (enterohepatic elimination).*†
Proportion of drug excreted via the kidney of select DPP-4 inhibitors1,4,5*†
Clinical significance has not been established.
Comparative clinical significance unknown.
A small fraction of absorbed linagliptin is metabolized into a pharmacologically inactive metabolite.
Are you thinking Trajenta®?
![Healthcare professional and patient Healthcare professional and patient](https://pro.boehringer-ingelheim.com/ca/products/trajenta/images/login-banner-updated.png)
Are you a Canadian
View coverage details for Trajenta® and Jentadueto®
![Map of Canada Map of Canada](https://pro.boehringer-ingelheim.com/ca/products/trajenta/images/check-coverage-icon.png)